Efficacy and Safety of AbobotulinumtoxinA in Pediatric Lower Limb Spasticity: Interim Results from a Phase IV, Prospective, Observational, Multicenter Study

Authors

Mark E. Gormley, Gillette Children's Specialty Healthcare, St. Paul, MN
Edward Dabrowski, Oakland University School of Medicine, Grosse Point, MI
Mauricio R. Delgado, University of Texas Southwestern Medical Center, Dallas, TX
Ann Tilton, LSU Health Sciences Center - New OrleansFollow
Asare Christian, Good Shepherd Rehabilitation Hospital, Allentown, PA
Sarah Helen Evans, Children's Hospital of Philadelphia, Philadelphia, PA
Pascal Maisonobe, Ipsen, Boulogne-Billancourt,Ile-de-France, France
Stefan Wietek, Ipsen, Cambridge, MA
Bruce Rubin, Ipsen Bioscience

Document Type

Conference Proceeding

Publication Date

4-14-2020

Publication Title

Neurology

Abstract

72nd Annual Meeting of the American Academy of Neurology, AAN 2020, April 25 - May 1, 2020, Toronto, Canada

First Page

1343

Volume

94

Issue

15 Supplement

Comments

Abstract 1343

Rights

© 2020, Wolters Kluwer Health

Recommended Citation

Gormley, Mark E.; Dabrowski, Edward; Delgado, Mauricio R.; Tilton, Ann; Christian, Asare; Evans, Sarah Helen; Maisonobe, Pascal; Wietek, Stefan; and Rubin, Bruce, "Efficacy and Safety of AbobotulinumtoxinA in Pediatric Lower Limb Spasticity: Interim Results from a Phase IV, Prospective, Observational, Multicenter Study" (2020). School of Medicine Faculty Publications. 4146.
https://digitalscholar.lsuhsc.edu/som_facpubs/4146
10.1212/WNL.94.15_supplement.1343